iCoat Medical has been given the opportunity to present its preclinical data of TUM012 at the 14th International Conference on Complement Therapeutics in Rhodes, Greece in June 2022.
Chief Technology Officer Professor Bo Nilsson will present iCoat Medical’s work for an audience consisting of experts in clinical complement system biology and representing pharmacological companies developing complement therapeutics.
For more information, please contact:
Bo Nilsson, CTO – iCoat Medical AB
Peder Waern, CEO – iCoat Medical AB